These large-cap U.S. REIT stocks are screening cheapest based on valuation grades
Seeking Alpha News (Tue, 2-Jun 2:35 PM ET)
Fermi is the best performing real estate stock in the past month
Seeking Alpha News (Fri, 29-May 11:33 AM ET)
Market Chameleon (Wed, 6-May 3:50 AM ET)
Business Wire (Tue, 5-May 4:15 PM ET)
Business Wire (Wed, 8-Apr 4:15 PM ET)
Healthpeak Properties Declares Monthly Common Stock Cash Dividends for the Second Quarter of 2026
Business Wire (Mon, 6-Apr 4:15 PM ET)
Globe Newswire (Tue, 24-Mar 10:00 AM ET)
Healthpeak Properties Closes New $400 Million Delayed-Draw Term Loan Facility
Business Wire (Mon, 23-Mar 4:16 PM ET)
Healthpeak Properties and Janus Living Announce Closing of Janus Living Initial Public Offering
Business Wire (Mon, 23-Mar 4:15 PM ET)
Business Wire (Thu, 19-Mar 4:35 PM ET)
Healthpeak owns a diversified healthcare portfolio of approximately 700 in-place properties spread across mainly medical office and life science assets, plus a handful of senior housing, hospital, and skilled nursing/post-acute care assets, as well.
Healthpeak Properties trades on the NYSE stock market under the symbol DOC.
As of June 2, 2026, DOC stock price climbed to $19.45 with 7,044,846 million shares trading.
DOC has a beta of 0.85, meaning it tends to be less sensitive to market movements. DOC has a correlation of 0.12 to the broad based SPY ETF.
DOC has a market cap of $13.41 billion. This is considered a Large Cap stock.
Last quarter Healthpeak Properties reported $753 million in Revenue and $.45 earnings per share. This beat revenue expectation by $64 million and exceeded earnings estimates by $.02.
In the last 3 years, DOC traded as high as $23.26 and as low as $10.52.
The top ETF exchange traded funds that DOC belongs to (by Net Assets): VNQ, VTI, VOO, VB, RSP.
DOC has underperformed the market in the last year with a price return of +18.7% while the SPY ETF gained +30.1%. However, in the short term, DOC had mixed performance relative to the market. It has outperformed in the last 3 months, returning +11.7% vs +11.0% return in SPY. But in the last 2 weeks, DOC shares have been beat by the market, returning -0.2% compared to an SPY return of +2.8%.
DOC support price is $18.71 and resistance is $19.29 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DOC shares will trade within this expected range on the day.